As part of the growing concern of hospital- acquired infections, in August 2019, AGAVI LTD Air performed a trial in collaboration with The Infections Department of The SHARY ZEDEK Medical Center in the installation of AGAVI filter for the purpose of disinfecting and purifying the air from various pollutants.
Initial results showed a remarkable ability of the purification filter to disinfect various bacteria. With the outbreak of the COVID-19 pandemic, in Wuhan, China, focus of the global medical community has changed from preventing hospital acquired bacterial infections into preventing viral spread of SARS-CoV-2.
Previous experimental results obtained in collaboration with AGAVI LTD Air demonstrate the ability to filter a series of high-risk pathogens including various viruses, such as Influenza H1N1 and Influenza H5N1. We were able to obtain a Coronavirus and build a model to test filter for their ability to filter or eliminate the virus. In May 2019, the company began a clinical experiment to test the effectiveness of AGAVI filter disinfection capabilities on the Coronavirus. The aim of the trial was to quantify the properties of the AGAVI filter to purify air contaminated by a Coronavirus similar in size with the SARS-Cove- 2.
Tiếng Việt
English
Tiếng thái lan
日本語
한국어
中文 (简体)
Español
Tiếng Campuchia
Tiếng Lào
Tiếng Indonesia
Tiếng Pháp
Tiếng Đức
Tiếng Arap
Tiếng Bồ Đào Nha
Tiếng Do Thái
